The relationship of pan-immune-inflammation value (PIV) and HALP score with prognosis in patients with atrial fibrillation.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
06 Sep 2024
06 Sep 2024
Historique:
medline:
10
9
2024
pubmed:
10
9
2024
entrez:
10
9
2024
Statut:
ppublish
Résumé
Because earlier studies have proven a link between hemoglobin, albumin, lymphocyte, and platelet (HALP) and pan-immune-inflammation value (PIV) scores and inflammation, we examined if these 2 markers had predictive value in patients with atrial fibrillation (AF). In the intensive care unit, 444 patients with and without AF were retrospectively analyzed. Patients with and without AF were compared with regard to their HALP and PIV scores. High and low categories of HALP and PIV scores were established based on the cutoff values. Furthermore, using receiver operating characteristic analysis, the mortality predictive efficacy of these scores was assessed in 230 patients with AF. Patients with AF had a significantly higher PIV score than those without AF; however, the HALP score found to be lower (P < .05 for all groups). The receiver operating characteristic analysis revealed that the HALP score exhibited a sensitivity of 66.7% and a specificity of 75.3% at a cutoff value of 2.037 (AUC: 0.753, P < .001). The PIV score cutoff value was 1062.7, but the sensitivity and specificity were both 55.7% and 55.8%, respectively (AUC: 0.571, P < .05). The mechanical ventilation requirement and in-hospital mortality rate were significantly higher in the high PIV (PIV > 1062.7) and low HALP (HALP ≤ 2.037) groups. There is a significant association between the HALP and PIV scores assessed upon admission and critically ill patients with AF. Although the HALP score serves as a powerful prognostic factor for these patients, the PIV lacks the capability to predict mortality.
Identifiants
pubmed: 39252218
doi: 10.1097/MD.0000000000039643
pii: 00005792-202409060-00005
doi:
Substances chimiques
Biomarkers
0
Hemoglobins
0
Serum Albumin
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e39643Informations de copyright
Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors have no funding and conflicts of interest to disclose.
Références
Bosch NA, Cimini J, Walkey AJ. Atrial fibrillation in the ICU. Chest. 2018;154:1424–34.
Li W, Song Y. Red cell distribution width to albumin ratio is a risk factor for atrial fibrillation in subjects hospitalized with coronary angiography. BMC Cardiovasc Disord. 2024;24:95.
Gu YL, Yang D, Huang ZB, Chen Y, Dai ZS. Relationship between red blood cell distribution width-to-albumin ratio and outcome of septic patients with atrial fibrillation: a retrospective cohort study. BMC Cardiovasc Disord. 2022;22:538.
Pan LY, Song J. Association of red cell distribution width/albumin ratio and in hospital mortality in patients with atrial fibrillation base on medical information mart for intensive care IV database. BMC Cardiovasc Disord. 2024;24:174.
Sivri F, Güngör H, Çokpinar S, Sezgin BA, Zencir C. Value of preoperative platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios in predicting postoperative atrial fibrillation in patients undergoing lung resection. J Tehran Heart Cent. 2022;17:236–42.
Bonde AN, Blanche P, Staerk L, et al. Oral anticoagulation among atrial fibrillation patients with anaemia: an observational cohort study. Eur Heart J. 2019;40:3782–90.
Yuan HJ, Zhong X, Li Y, Xue YT, Jiao HC. Correlation between serum albumin and D-dimer levels in 909 patients with non-valvular atrial fibrillation: a retrospective study from a single center in China. Med Sci Monit. 2022;28:e938511.
Kocaoglu S, Alatli T. The efficiency of the HALP score and the modified HALP score in predicting mortality in patients with acute heart failure presenting to the emergency department. J Coll Physicians Surg Pak. 2022;32:706–11.
Zheng Y, Huang Y, Li H. Hemoglobin albumin lymphocyte and platelet score and all-cause mortality in coronary heart disease: a retrospective cohort study of NHANES database. Front Cardiovasc Med. 2023;10:1241217.
Karakayali M, Omar T, Artac I, et al. The prognostic value of HALP score in predicting in-hospital mortality in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Coron Artery Dis. 2023;34:483–8.
Cetinkaya Z, Kelesoglu S, Tuncay A, et al. The role of pan-immune-inflammation value in determining the severity of coronary artery disease in NSTEMI patients. J Clin Med. 2024;13:1295.
Kutlay O, Yalim Z, Aktan AK. Inflammatory biomarkers derived from whole blood cell count in atrial fibrillation patients. Kardiologiia. 2023;63:50–5.
Guan YZ, Yin RX, Zheng PF, Liu CX, Wei BL, Deng GX. Association of RDW, NLR, and PLR with atrial fibrillation in critical care patients: a retrospective study based on propensity score matching. Dis Markers. 2022;2022:2694499.
Li Q, Nie J, Cao M, Luo C, Sun C. Association between inflammation markers and all-cause mortality in critical ill patients with atrial fibrillation: analysis of the multi-parameter intelligent monitoring in intensive care (MIMIC-IV) database. Int J Cardiol Heart Vasc. 2024;51:101372.
Şen Uzeli U, Başaran PO. Pan-immune inflammation value as a biomarker in ankylosing spondilitis and associated with disease activity. Anatolian Curr Med J. 2024;6:48–54.
Sargin ZG, Dusunceli I. The effect of HALP score on the prognosis of gastric adenocarcinoma. J Coll Physicians Surg Pak. 2022;32:1154–9.
Ustaoglu M, Aktas G, Kucukdemirci O, Goren I, Bas B. Could a reduced hemoglobin, albumin, lymphocyte, and platelet (HALP) score predict autoimmune hepatitis and degree of liver fibrosis. Rev Assoc Med Bras (1992). 2024;70:e20230905.
Bildik B, Çekmen B, Atiş SE, Günaydin YK, Dorter M. Evaluation of the relationship between Hemoglobin, Albumin, Lymphocyte, Platelet (HALP) score and treatment modality and mortality in patients with ileus. Ulus Travma Acil Cerrahi Derg. 2023;29:1351–6.
Zuo L, Dong Y, Liao X, et al. Low HALP (Hemoglobin, Albumin, Lymphocyte, and Platelet) score increases the risk of post-stroke cognitive impairment: a multicenter cohort stud. Clin Interv Aging. 2024;19:81–92.
Xiang W, Chen X, Ye W, Li J, Zhang X, Xie D. Prognostic nutritional index for predicting 3-month outcomes in ischemic stroke patients undergoing thrombolysis. Front Neurol. 2020;11:599.
Wang Y, Du P, Xiao Q, et al. Relationship between serum albumin and risk of atrial fibrillation: a dose-response meta-analysis. Front Nutr. 2021;8:728353.
Liu L, Gong B, Wang W, Xu K, Wang K, Song G. Association between haemoglobin, albumin, lymphocytes, and platelets and mortality in patients with heart failure. ESC Heart Fail. 2024;11:1051–60.
Pan H, Lin S. Association of hemoglobin, albumin, lymphocyte, and platelet score with risk of cerebrovascular, cardiovascular, and all-cause mortality in the general population: results from the NHANES 1999-2018. Front Endocrinol (Lausanne). 2023;14:1173399.
Turan YB. The prognostic importance of the pan-immune-inflammation value in patients with septic shock. BMC Infect Dis. 2024;24:69.
Hai-Jing Y, Shan R, Jie-Qiong X. Prognostic significance of the pretreatment pan-immune-inflammation value in cancer patients: an updated meta-analysis of 30 studies. Front Nutr. 2023;10:1259929.
Ocak T, Lermi N, Yilmaz BZ, et al. Pan-immune-inflammation value could be a new marker to differentiate between vascular Behçet’s disease and non-vascular Behçet’s disease. Eur Rev Med Pharmacol Sci. 2024;28:1751–9.
Zhang F, Li L, Wu X, et al. Pan-immune-inflammation value is associated with poor prognosis in patients undergoing peritoneal dialysis. Ren Fail. 2023;45:2158103.
Murat B, Murat S, Ozgeyik M, Bilgin M. Comparison of pan-immune inflammation value with other inflammation markers of long-term survival after ST-segment elevation myocardial infarction. Eur J Clin Invest. 2023;53:e13872.
Wu B, Zhang C, Lin S, Zhang Y, Ding S, Song W. The relationship between the pan-immune-inflammation value and long term prognoses in patients with hypertension: National Health and Nutrition Examination Study, 1999–2018. Front Cardiovasc Med. 2023;10:1099427.